Purchase Order 75N91021P00977
Award Date
9/30/21
Potential Completion Date
9/29/22
Potential Value
$80K
Federal Agency
National Cancer Institute
Ultimate Awardee
State Of California Controllers Office
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94143, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) has awarded a $50,000.00 firm fixed-price purchase order to the Regents of the University of California, San Francisco (UCSF) to obtain historical samples of frozen tumor tissue and adjacent normal lung tissue from never-smoking lung cancer patients, along with accompanying medical documentation and data. This purchase order is part of the NCI's Sherlock-Lung study, an international whole-genome sequencing study of...
This is a firm-fixed price purchase order contract awarded by the National Institutes of Health (NIH), which is part of the U.S. Department of Health and Human Services (DHHS), to the National University of Singapore. The contract is for $105,750.00 to provide tissue sample and medical record preparation services in support of the SHERLOCK-LUNG study on never-smoking lung cancer cases in Singapore. This research supports the NIH's work in studying lung cancer. The National University of...
The University of California, San Francisco (UCSF) has been awarded a $155,104.99 delivery order contract by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The contract is part of the Surveillance, Epidemiology, and End Results (SEER) Program, which aims to collect and analyze data on cancer incidence and survival in the United States. Under this contract, UCSF will conduct a pilot project to develop and implement whole slide imaging capabilities for...
This is a delivery order contract awarded by the National Cancer Institute (NCI) to The Regents of the University of California, San Francisco (UCSF) for the Cancer Genome Atlas (TCGA) program. The contract, valued at $24,087.50, is for the acquisition of tissue samples and data from various types of cancer to support the TCGA program, which is part of the American Recovery and Reinvestment Act (ARRA). The contract does not have a set-aside designation and is a firm fixed-price type. UCSF, as...
This is a delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to The Regents of the University of California, San Francisco (UCSF) for the NCI SEER Patterns of Care (POC)/Quality of Care Study for diagnosis year 2019, focusing on urinary bladder cancer and kidney cancer. The $178,096 firm fixed price contract is part of the Surveillance Epidemiology and End Results (SEER) program master indefinite...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian federal agency, to the National Cancer Center, a Japanese research and development agency. The contract is for $24,000.00 and requires the awardee to provide laboratory testing services, including whole-genome scans and phenotype data preparation, on 1,000 never-smoking female lung adenocarcinoma cases in Japan. The contract has an ultimate completion date of December 9, 2025. This contract...
This is a federal contract award to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, for the Surveillance, Epidemiology, and End Results (SEER) Program. The contract, valued at $49,138,339.20, is a delivery order awarded by the National Cancer Institute, a part of the U.S. Department of Health and Human Services, with a period of performance from May 1, 2018 to April 30, 2028. The contract is not set aside for any...
This is a $1,379,807.12 federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF). The contract is for biomedical (applied/exploratory) research and does not have a set-aside designation. UCSF is a leading academic medical center and research institution that receives substantial federal funding for biomedical research, healthcare services,...
This is a federal contract award from the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $7,053,827.00, was awarded to the University of Maryland, Baltimore (UMB) to serve as a resource for the collection of human tissue, cells, biofluids, and epidemiologic profiles from donors to support NCI's Laboratory of Human Carcinogenesis research programs. The contract has a 1-year base period and four 1-year option...
This firm fixed-price purchase order contract, valued at $244,997.45, was awarded by the National Cancer Institute (NCI) to the University of Manchester, a private university and non-profit educational institution based in the United Kingdom. The contract supports the NCI's Sherlock-Lung Study, which is analyzing cancerous and healthy tissue samples from up to 2,000 never-smoking and 500 smoking lung cancer patients. The University of Manchester will conduct multi-omics analyses to elucidate the...